MUMBAI Shares of Ranbaxy Laboratories(RANB.NS) fell as much as 2.7 percent after the drug maker said on Tuesday it has suspended shipments of pharmaceutical ingredients produced at its Toansa and Dewas plants.
"This voluntary decision was taken as a precautionary measure and out of abundant caution to better allow the company to assess and review the processes and controls. The company will resume shipments after reassuring them about the processes and controls at these facilities," Ranbaxy said in an exchange filing.
Ranbaxy shares were trading up 0.7 percent at 11.46 a.m.
(Reporting by Abhishek Vishnoi; Editing by Subhranshu Sahu)
Asia shares slip, crude steadies; US jobs in focus
TOKYO Asian shares dipped on Thursday after lower crude oil prices dented Wall Street and a pair of Chinese manufacturing surveys did little to inspire investors as markets waited to see if U.S. employment data could put the Federal Reserve on track to hike interest rates.
China factory activity unexpectedly expands in August - official PMI
BEIJING Activity in China's manufacturing sector picked up unexpectedly in August but gains were modest, an official survey showed on Thursday, suggesting the world's second-largest economy is steadying but still sluggish.
Indian growth slows sharply in April-June quarter
NEW DELHI India's economic growth hit a 15-month low between April and June, putting Prime Minister Narendra Modi's target further out of reach and making it tougher for him to create millions of new jobs for a burgeoning workforce.